Dave Weiner

Stock Analyst at Piper Sandler

(2.96)
# 2,219
Out of 4,786 analysts
7
Total ratings
100%
Success rate
57.97%
Average return

Stocks Rated by Dave Weiner

Myriad Genetics
Mar 12, 2025
Upgrades: Overweight
Price Target: $12$13
Current: $8.87
Upside: +40.92%
lululemon athletica inc.
Dec 14, 2017
Upgrades: Buy
Price Target: n/a
Current: $283.06
Upside: -